• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or continue ADHD medications during pregnancy and breastfeeding is challenging for women with the condition. There aren't many studies on how exposure to ADHD for a long time could affect the pregnant fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication in utero do not develop neurological developmental disorders such as hearing or vision impairment seizures, febrile seizures, or IQ impairment. The authors acknowledge the need for higher-quality research.

Risk/Benefit Analysis

Women who are pregnant and take ADHD medication should evaluate the benefits of using it against the possible dangers for the foetus. Doctors don't have enough data to give clear advice however they can provide information about risks and benefits to assist pregnant women to make informed decisions.

A study published in Molecular Psychiatry concluded that women who took ADHD medication in early pregnancy were not at a greater risk of fetal malformations or structural birth defects. Researchers conducted a massive population-based case control study to examine the prevalence of major structural defects in infants born to mothers who were taking stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts examined the cases to confirm that the classification was accurate and to minimize any bias.

The study of the researchers was not without its limitations. Researchers were unable to, in the first place, to separate the effects caused by the medication from the disorder. This makes it difficult for researchers to establish whether the small differences observed between the groups exposed were due to the use of medications or if they were affected by the presence of comorbidities. The researchers did not look at the long-term effects for the offspring.

The study showed that babies whose mothers had taken ADHD medication during pregnancy had a greater risk of being admitted to the neonatal care unit (NICU) in comparison to mothers who didn't take any medication during pregnancy or quit taking the medication prior to or during pregnancy. This was due to central nervous system disorders. The increased risk of admission was not influenced by the stimulant medications used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher risk of having to have an emergency caesarean section or having a baby that scored low on the Apgar scale (less than 7). These increases did not appear to be affected by the type of medication that was used during pregnancy.

The researchers suggest that the small risk associated with the use of ADHD medications during the early stages of pregnancy could be offset by the greater benefits to both the mother and child from continued treatment for the woman's disorder. Physicians should discuss the issue with their patients and, when they are able, assist them in developing strategies to improve coping skills that can lessen the negative impact of her condition on her daily life and relationships.

Medication Interactions

As more women than ever before are being diagnosed with ADHD and treated with medication, the question of whether to keep or stop treatment during pregnancy is one that doctors are having to have to face. Often, these decisions are taken in the absence of solid and reliable evidence in either case, which adhd medication is the best means that doctors have to weigh their experience about their experiences, the experiences of other doctors, and what research suggests about the subject as well as their own judgments for each individual patient.

Particularly, the issue of potential risks for the baby can be a challenge. The research on this issue is based on observations rather than controlled studies and the results are contradictory. The majority of studies focus on live-births, which could underestimate the teratogenic impact leading to terminations or abortions of pregnancy. The study that is discussed in the journal club addresses these shortcomings, by examining both data on live and deceased births.

Conclusion A few studies have revealed an association between ADHD medications and certain birth defects However, other studies haven't found a correlation. Most studies have shown an unintended, or somewhat negative, effect. In every case it is imperative to conduct a thorough analysis of the benefits and risks is required.

It can be difficult, if not impossible, for women with ADHD to stop taking their medication. In a recent piece published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of isolation. A decrease in medication could also impact the ability to drive safely and complete work-related tasks, which are crucial aspects of daily life for those suffering from ADHD.

She recommends women who are unsure about whether to continue or stop taking medication because of their pregnancy consider informing family members, friends and colleagues on the condition, its effects on daily life, and the advantages of staying on the current treatment regimen. It can also help a woman feel more confident in her decision. Some medications can pass through the placenta. If a woman decides to stop taking her ADHD medication while pregnant and breastfeeding, it is important to be aware that the drug could be passed on to her baby.

Risk of Birth Defects

As the use and misuse of ADHD medications to treat the symptoms of attention deficit disorder hyperactivity disorder (ADHD), increases the concern over the potential effects of these drugs on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this topic. Researchers used two massive data sets to study over 4.3 million pregnancies and determine whether stimulant medications increased birth defects. Researchers found that while the risk overall is low, first-trimester Adhd medication Pregnancy medication exposure was associated with slightly higher rates of specific heart defects like ventriculoseptal defects.

The researchers of the study found no connection between the use of early medications and other congenital abnormalities, such as facial clefting or club foot. The results are in the same vein as previous studies that showed a small, but significant increase in the number of cardiac malformations among women who started taking ADHD medication prior to the time of pregnancy. This risk increased during the latter stages of pregnancy when many women stopped taking their medication.

Women who were taking ADHD medication in the first trimester were more likely require a caesarean delivery or have a low Apgar after delivery and had a baby that required help breathing when they were born. The researchers of the study could not eliminate selection bias because they limited their study to women without other medical conditions that might have contributed to the findings.

The researchers hope that their research will aid in the clinical decisions of physicians who see pregnant women. The researchers recommend that while discussing risks and benefits are important, the decision regarding whether or not to stop taking medication should be according to the severity of each woman's online adhd medication symptoms and her needs.

The authors also warn that, while stopping the medication is an option, it is not an option that is recommended due to the high rate of depression and other mental health issues for women who are expecting or postpartum. Furthermore, research suggests that women who decide to stop taking their medications are more likely to experience a difficult time adjusting to life without them following the birth of their baby.

Nursing

The responsibilities of being a new mother can be overwhelming. Women with ADHD who have to manage their symptoms while attending physician appointments as well as preparing for the arrival of their child and adjusting to new household routines may face a lot of challenges. As such, many women elect to continue taking their ADHD medications throughout the course of pregnancy.

The risk to breastfeeding infant is not too high since the majority of stimulant medication passes through breast milk at low levels. However, the amount of exposure to medications by the infant can differ based on the dosage, frequency it is taken and at what time the medication is administered. In addition, different medications are introduced into the baby's system via the gastrointestinal tract or breast milk. The effect on the health of a newborn isn't completely known.

Some physicians may discontinue stimulant medications during a woman's pregnancy due to the lack of research. This is a complicated decision for the patient, who must weigh the benefits of keeping her medication with the potential risks to the embryo. In the meantime, until more information is available, GPs should ask all pregnant patients about their experience with ADHD and if they are taking or planning to take medication during the perinatal time.

Numerous studies have demonstrated that women can continue to take their ADHD medication in a safe manner while breastfeeding and during pregnancy. In response, an increasing number of patients are choosing to do this. They have concluded after consulting with their doctor that the benefits of continuing their current medication outweigh any potential risks.

Women with ADHD who plan to breastfeed should seek advice from a specialist psychiatrist before becoming pregnant. They should review their medications with their doctor and discuss the pros and cons of continued treatment, including non-pharmacological strategies. Psychoeducation is also needed to help pregnant women with adhd medication ritalin recognize the signs and underlying disorder. They should also learn about treatment options and build coping mechanisms. This should be a multidisciplinary effort including obstetricians, GPs and psychiatry. Pregnancy counseling should include discussion of a treatment plan for the mother as well as the child, as well as monitoring for signs of deterioration and, if needed, adjustments to the medication regime.